Clinical Trials Browser

Pathologic Complete Response

NCT05161572 2025-06-18

NeoRacing

Phase 2 Terminated

6 enrolled

Gastrointestinal

Adenocarcinoma, Stomach Neoplasms

NCT06662877 2024-10-29

Anlotinib Plus Nab-Paclitaxels and S-1 for Patients with Advanced Biliary Tract Cancer As Second-Line Treatment

Phase 2/3 Not yet recruiting

206 enrolled

Gastrointestinal

Biliary Tract Neoplasms

NCT01285557 2024-09-19

DIGEST

Phase 3 Terminated

361 enrolled 18 charts

Gastrointestinal

Stomach Neoplasms

NCT01845337 2023-05-12

TOFFEE

Phase 2 Completed

59 enrolled

Gastrointestinal

Bile Duct Neoplasms, Gastrointestinal Neoplasms, Neoplasms, Unknown Primary, Pancreatic Neoplasms

NCT05813015 2023-04-14

Study of Comparing of With and Without Sequential Therapy of S-1

Phase 3 Recruiting

70 enrolled

Gastrointestinal

Locally Advanced Gastric Adenocarcinoma

NCT02191566 2022-12-08

SOHUG

Phase 2 Terminated

8 enrolled

Gastrointestinal

Stomach Neoplasms

NCT05396326 2022-05-31

A Pilot Study of Neoadjuvant TACiE in Locally Advanced Gastric Cancer

Phase 1 Unknown

20 enrolled

Gastrointestinal

Stomach Neoplasms

NCT05346874 2022-05-26

Neoadjuvant TACiE in Locally Advanced Gastric Cancer

Phase 2 Unknown

37 enrolled

Gastrointestinal

Stomach Neoplasms

NCT03904225 2021-06-23

Tegio Consolidation Therapy for NPC Patients With High Risk of Metastasis

Phase 2 Unknown

220 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02564367 2021-04-29

S-1 adjuvant

Phase 1/2 Completed

30 enrolled

Tumor-Agnostic

Adenocarcinoma

NCT02128243 2021-03-26

MATEO

Phase 2 Completed

242 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Neoplasm Metastasis, Stomach Neoplasms

NCT04377048 2020-05-06

Nivolumab Adding on Gemcitabine/S-1 in Metastatic Pancreatic Cancer

Phase 2 Unknown

38 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT02347904 2019-11-18

SOX

Phase 1 Completed

40 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT02216149 2018-08-28

FluoHeart

Phase 2 Terminated

20 enrolled

Gastrointestinal

Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Rectal Neoplasms, Stomach Neoplasms

NCT01918852 2018-03-14

SALTO

Phase 3 Completed

161 enrolled

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms, Hand-Foot Syndrome

NCT01704690 2017-04-07

Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer

Phase 2/3 Terminated

4 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT02867397 2016-08-15

Study of Teysuno (S-1) Combined With Epirubicin and Oxaliplatin in Patients With Advanced Solid Tumors

Phase 1 Completed

25 enrolled

Other solid neoplasm

Patients With Advanced or Metastatic Solid Tumors

NCT01608646 2012-05-31

Study of DPD for Predicting Efficacy and Safety to S-1 Plus Oxaliplatin in Gastrointestinal Cancer

Phase 2 Unknown

200 enrolled

Gastrointestinal

Gastrointestinal Neoplasms

Clinical Trials

MEND-IT II

NeoRacing

Anlotinib Plus Nab-Paclitaxels and S-1 for Patients with Advanced Biliary Tract Cancer As Second-Line Treatment

DIGEST

TOFFEE

Study of Comparing of With and Without Sequential Therapy of S-1

SOHUG

A Pilot Study of Neoadjuvant TACiE in Locally Advanced Gastric Cancer

Neoadjuvant TACiE in Locally Advanced Gastric Cancer

Tegio Consolidation Therapy for NPC Patients With High Risk of Metastasis

S-1 adjuvant

MATEO

Nivolumab Adding on Gemcitabine/S-1 in Metastatic Pancreatic Cancer

SOX

FluoHeart

SALTO

Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer

Study of Teysuno (S-1) Combined With Epirubicin and Oxaliplatin in Patients With Advanced Solid Tumors

Study of DPD for Predicting Efficacy and Safety to S-1 Plus Oxaliplatin in Gastrointestinal Cancer